Jessica Jingxian Cai

Jessica Jingxian Cai

Regeneron Pharmaceuticals Inc - Warsaw / United States
Others
AD Scientific Index ID: 5441067
-
person_outline Jessica Jingxian Cai's MOST POPULAR ARTICLES
1-) Chinese social media reaction to information about 42 notifiable infectious diseasesICH Fung, Y Hao, J Cai, Y Ying, BJ Schaible, CM Yu, ZTH Tse, KW FuPLoS One 10 (5), e0126092, 2015522015
2-) Odronextamab in patients with Relapsed/Refractory (R/R) follicular lymphoma (FL) Grade 1-3a: results from a prespecified analysis of the pivotal phase II study ELM-2TM Kim, M Taszner, SG Cho, S Novelli, S Le Gouill, ML Poon, ...Blood 140 (Supplement 1), 2280-2282, 2022192022
3-) Global Handwashing Day 2012: a qualitative content analysis of Chinese social media reaction to a health promotion eventICH Fung, J Cai, Y Hao, Y Ying, BSB Chan, ZTH Tse, KW FuWestern Pacific surveillance and response journal: WPSAR 6 (3), 34, 2015182015
4-) A simpler approach for mediation analysis for dichotomous mediators in logistic regressionH Samawi, J Cai, DF Linder, H Rochani, J YinJournal of Statistical Computation and Simulation 88 (6), 1211-1227, 2018152018
5-) Results of a second, prespecified analysis of the phase 2 study ELM-2 confirm high rates of durable complete response with odronextamab in patients with relapsed/refractory (R …JC Villasboas, TM Kim, M Taszner, S Novelli, SG Cho, M Merli, AJ Ubieto, ...Blood 142, 3041, 2023112023